DUSA PHARMACEUTICALS INC
CIK 0000879993
Revenue (TTM)
—
Q3 Nov 2012
Net Income (TTM)
$3.93M
+170.8% YoY
Q3 Nov 2012
EPS Diluted (TTM)
$0.19
+154.5% YoY
Q3 Nov 2012
Gross Margin
—
Q3 Nov 2012
Operating Margin
—
Q3 Nov 2012
Net Margin
—
Q3 Nov 2012
Free Cash Flow (TTM)
$7.58M
Q3 Nov 2012
Cash
$28.74M
Q3 Nov 2012
Total Debt
—
Q3 Nov 2012
Shares Outstanding
25.03M sh
Q3 Nov 2012
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.